Neutralizing Antibodies

Neutralizing antibodies alone are insufficient to measure severe disease risk from Omicron. Antibody-mediated neutralization is only one component of vaccine-induced immunity. Neutralizing antibodies indicate the likelihood of infection, not risk of severe disease. Antibodies can still neutralize Omicron when present at sufficiently high concentrations, despite substantially reduced effectiveness.